The Ensign Group (ENSG) Competitors

$118.34
+0.64 (+0.54%)
(As of 05/10/2024 ET)

ENSG vs. PACS, GMED, HQY, ACHC, PCVX, EXEL, ITCI, ELAN, JAZZ, and CYTK

Should you be buying The Ensign Group stock or one of its competitors? The main competitors of The Ensign Group include PACS Group (PACS), Globus Medical (GMED), HealthEquity (HQY), Acadia Healthcare (ACHC), Vaxcyte (PCVX), Exelixis (EXEL), Intra-Cellular Therapies (ITCI), Elanco Animal Health (ELAN), Jazz Pharmaceuticals (JAZZ), and Cytokinetics (CYTK). These companies are all part of the "medical" sector.

The Ensign Group vs.

The Ensign Group (NASDAQ:ENSG) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

The Ensign Group presently has a consensus target price of $124.60, indicating a potential upside of 5.33%. PACS Group has a consensus target price of $30.50, indicating a potential upside of 24.39%. Given PACS Group's stronger consensus rating and higher probable upside, analysts plainly believe PACS Group is more favorable than The Ensign Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Ensign Group
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
PACS Group
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

The Ensign Group has higher revenue and earnings than PACS Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Ensign Group$3.85B1.76$209.40M$3.8031.28
PACS Group$3.11B1.18N/AN/AN/A

96.1% of The Ensign Group shares are owned by institutional investors. 3.9% of The Ensign Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, PACS Group had 25 more articles in the media than The Ensign Group. MarketBeat recorded 35 mentions for PACS Group and 10 mentions for The Ensign Group. The Ensign Group's average media sentiment score of 0.72 beat PACS Group's score of 0.22 indicating that The Ensign Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Ensign Group
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
5 Very Positive mention(s)
3 Positive mention(s)
16 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Neutral

The Ensign Group has a net margin of 5.67% compared to PACS Group's net margin of 0.00%. The Ensign Group's return on equity of 17.60% beat PACS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Ensign Group5.67% 17.60% 6.33%
PACS Group N/A N/A N/A

The Ensign Group received 345 more outperform votes than PACS Group when rated by MarketBeat users. However, 100.00% of users gave PACS Group an outperform vote while only 66.10% of users gave The Ensign Group an outperform vote.

CompanyUnderperformOutperform
The Ensign GroupOutperform Votes
351
66.10%
Underperform Votes
180
33.90%
PACS GroupOutperform Votes
6
100.00%
Underperform Votes
No Votes

Summary

The Ensign Group beats PACS Group on 9 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ENSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ENSG vs. The Competition

MetricThe Ensign GroupSkilled nursing care facilities IndustryMedical SectorNASDAQ Exchange
Market Cap$6.77B$2.69B$5.16B$7.77B
Dividend Yield0.21%1.79%2.84%3.96%
P/E Ratio31.2817.24189.0818.93
Price / Sales1.761.142,315.6988.59
Price / Cash20.3412.9633.6028.61
Price / Book4.502.585.254.58
Net Income$209.40M$87.04M$105.28M$217.41M
7 Day Performance1.70%0.00%-0.75%0.09%
1 Month Performance1.25%0.44%-2.72%-1.15%
1 Year Performance28.57%30.71%2.63%8.55%

The Ensign Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PACS
PACS Group
0 of 5 stars
$24.97
+1.1%
N/AN/A$3.75B$3.11B0.0032,433Upcoming Earnings
GMED
Globus Medical
4.5086 of 5 stars
$49.79
-1.6%
$66.33
+33.2%
+13.7%$6.74B$1.02B42.565,000Earnings Report
Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
HQY
HealthEquity
3.9203 of 5 stars
$78.91
-1.7%
$96.17
+21.9%
+39.4%$6.77B$999.59M123.303,150
ACHC
Acadia Healthcare
4.3816 of 5 stars
$73.94
-0.9%
$92.00
+24.4%
+2.6%$6.83B$2.93B-295.7523,500
PCVX
Vaxcyte
0.6576 of 5 stars
$60.55
-0.8%
$78.50
+29.6%
+23.0%$6.59BN/A-14.66254Earnings Report
Analyst Forecast
News Coverage
EXEL
Exelixis
4.8974 of 5 stars
$23.46
-1.1%
$26.29
+12.0%
+13.2%$6.92B$1.83B36.661,310Short Interest ↑
ITCI
Intra-Cellular Therapies
4.8083 of 5 stars
$71.81
-0.7%
$90.17
+25.6%
+2.5%$6.95B$464.37M-49.18610Earnings Report
Analyst Forecast
Analyst Revision
ELAN
Elanco Animal Health
3.1383 of 5 stars
$13.16
-3.0%
$16.71
+27.0%
+84.8%$6.50B$4.42B-5.269,300Earnings Report
Analyst Forecast
Short Interest ↓
Analyst Revision
News Coverage
JAZZ
Jazz Pharmaceuticals
4.8772 of 5 stars
$110.75
-0.4%
$195.08
+76.1%
-16.5%$6.98B$3.83B18.102,800Insider Selling
CYTK
Cytokinetics
4.2553 of 5 stars
$61.32
-1.9%
$79.33
+29.4%
+64.8%$6.41B$7.53M-11.25423Earnings Report
Analyst Forecast
Insider Selling
News Coverage

Related Companies and Tools

This page (NASDAQ:ENSG) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners